{
  "title": "New Booster Shot Targets Covid Variants More Effectively, Pfizer Says",
  "link": "https://www.nytimes.com/2022/11/04/us/politics/covid-booster-pfizer.html",
  "guid": "https://www.nytimes.com/2022/11/04/us/politics/covid-booster-pfizer.html",
  "atom:link": "",
  "description": "Federal officials are hoping that encouraging new findings will spur more Americans to get an updated booster before a feared surge in coronavirus cases this winter.",
  "dc:creator": "Sharon LaFraniere",
  "pubDate": "Sat, 05 Nov 2022 02:08:18 +0000",
  "category": [
    "Coronavirus (2019-nCoV)",
    "Pfizer Inc",
    "BioNTech SE",
    "Vaccination and Immunization",
    "Drugs (Pharmaceuticals)",
    "United States Politics and Government",
    "Research"
  ],
  "media:content": "",
  "media:credit": "Hannah Beier/Reuters",
  "media:description": "Only about 8 percent of Americans ages 5 and up have received the new boosters from Pfizer and Moderna since they were introduced in September."
}